Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Systems and methods for leadless cardiac resynchronization therapy

US Patent 10086206 · Granted Oct 2, 2018

Estimated economic value: $36,073,000

Assignee

Inventors

View full patent text on Google Patents →